Clinical Trials Logo

Sleep Disorders, Intrinsic clinical trials

View clinical trials related to Sleep Disorders, Intrinsic.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03734341 Completed - Clinical trials for Sleep Apnea, Obstructive

Comparison of Two Telemonitoring Auto-titrating Modalities in OSA Patients

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

This study compares the titration pressures achieved through two auto-titrating modalities, a new incremental fixed pressure mode versus routine auto-adjusting pressure mode, in CPAP-naïve obstructive sleep apnea patients. The aim of the study is to verify that this new modality achieves a lower titration pressure.

NCT ID: NCT02752139 Completed - Clinical trials for Sleep Disorders, Intrinsic

Cerebral Hemodynamics in Sleep Disorders

Start date: May 2016
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to determine the relationship between sleep disorders and cerebral hemodynamics.

NCT ID: NCT01047930 Completed - Smoking Clinical Trials

The Effect of Exercise on Acute Nicotine Withdrawal

NicEx
Start date: January 2010
Phase: N/A
Study type: Interventional

The primary aim of this project is to test the effect of exercise on acute nicotine withdrawal. Acute nicotine withdrawal is characterized by a complex array of symptoms associated with increased risk of relapse among individuals attempting smoking cessation. The available remedies do not target all aspects of withdrawal. For example, pharmacologic treatments reduce withdrawal-based craving, but have no effect on cue-related craving, altered sleep, and mood disturbances during withdrawal. Therefore, non-pharmacologic behavioral techniques with the potential to attenuate persistent withdrawal symptoms are needed. We hypothesized that exercise can be a valid non-pharmacologic strategy to improve these domains.

NCT ID: NCT00631657 Completed - Mental Disorders Clinical Trials

A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)

Start date: March 4, 2008
Phase: Phase 3
Study type: Interventional

To investigate the long-term efficacy and safety of treatment with esmirtazapine (Org 50081, SCH 900265, MK-8265) compared to placebo, in participants with chronic primary insomnia. Primary efficacy variable is Total Sleep Time (TST).

NCT ID: NCT00561574 Completed - Mental Disorder Clinical Trials

A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001)

Jade
Start date: January 9, 2008
Phase: Phase 3
Study type: Interventional

The current study is a 52-week safety study in elderly outpatients with chronic primary insomnia randomized to treatment with 1.5 mg or 3.0 mg of esmirtazapine (Org 50081, SCH 900265, MK-8265) to investigate the safety and tolerability of long-term treatment with esmirtazapine in elderly patients.

NCT ID: NCT00149747 Completed - Clinical trials for Sleep Initiation and Maintenance Disorders

The Effectiveness of Regular Exercise on Improving Sleep in Older Adults

RTC
Start date: August 1999
Phase: Phase 2/Phase 3
Study type: Interventional

This study will evaluate the effect of regular aerobic exercise on improving sleep in older adults with moderate difficulty sleeping.